Hims & Hers Health is planning to sell compounded peptides, the company said in a Monday earnings call. The company’s CEO, Andrew Dudum, said in the earnings call that it was “currently developing a best-in-class peptides experience, including U.S. manufactured products, clinical-led guidance, and ongoing blood testing.” Dudum said in the call that the company...
The Ukrainian president has warned that Russia is preparing for escalation and could use its parliamentary elections next month as a pretext to declare a new mobilization.
The watchdog's review warns the $4 billion federal funding loss now leaves the project needing billions in financing within 16 months — as the rail authority acknowledges for the first time that it…
